A latest artificial intelligence model is demonstrating remarkable accuracy in detecting acromegaly, a rare hormonal disorder, simply by analyzing photographs of the back of a person’s hand. The breakthrough, developed by researchers at Kobe University in Japan, offers a potentially faster and more accessible path to diagnosis for a condition that often goes undetected for years, sometimes even a decade, due to its gradual progression and relative obscurity. This advancement in early detection of acromegaly could significantly improve patient outcomes.
Acromegaly occurs when the pituitary gland produces too much growth hormone, typically caused by a noncancerous tumor. This excess hormone leads to the gradual enlargement of hands, feet and facial features. Beyond these visible changes, the condition can contribute to serious health problems, including type 2 diabetes, heart disease, and an increased risk of certain cancers. If left untreated, acromegaly can reduce life expectancy by approximately 10 years, according to the Rare Disease Advisor.
Currently, diagnosing acromegaly relies on a combination of blood tests to measure growth hormone and insulin-like growth factor 1 (IGF-1) levels, alongside medical imaging to identify pituitary tumors. But, the subtle and gradual nature of the disease often leads to delayed diagnosis. “Because the condition progresses so slowly, and because it is a rare disease, it is not uncommon to take up to a decade for it to be diagnosed,” explained Kobe University endocrinologist Fukuoka Hidenori. Previous attempts to utilize AI for early detection have focused on facial photographs, raising privacy concerns.
Addressing Privacy Concerns with Hand Analysis
The Kobe University team, led by graduate student Ohmachi Yuka, sought to overcome these privacy hurdles by focusing on hand images. “Trying to address this concern, we decided to focus on the hands, a body part we routinely examine alongside the face in clinical practice for diagnostic purposes, particularly because acromegaly often manifests changes in the hands,” Ohmachi stated. To further protect patient privacy, the researchers limited their analysis to images of the back of the hand and a clenched fist, avoiding the unique patterns found in palm lines.
This approach allowed them to amass a substantial dataset for training and validating their AI model. Over 11,000 images were collected from 725 patients across 15 medical facilities throughout Japan. The resulting model, detailed in the Journal of Clinical Endocrinology & Metabolism, demonstrated a high degree of sensitivity and specificity in identifying acromegaly. In fact, the AI’s performance surpassed that of experienced endocrinologists when evaluating the same hand photographs.
AI Outperforms Experts in Detection
“Frankly, I was surprised that the diagnostic accuracy reached such a high level using only photographs of the back of the hand and the clenched fist,” Ohmachi admitted. “What struck me as particularly significant was achieving this level of performance without facial features, which makes this approach a great deal more practical for disease screening.” The team’s research, published February 27, 2026, with DOI 10.1210/clinem/dgag027, suggests a promising new tool for identifying individuals who may require further medical evaluation.
The researchers are already looking beyond acromegaly, exploring the potential of their AI model to detect other conditions visible in hand images, such as rheumatoid arthritis, anemia, and finger clubbing. “This result could be the entry point for expanding the potential of medical AI,” Ohmachi noted. The team envisions a future where AI-powered screening tools become integrated into routine health check-ups, facilitating earlier diagnosis and intervention for a wider range of conditions.
Complementing Clinical Expertise, Reducing Disparities
The Kobe University team emphasizes that their AI model is not intended to replace clinical judgment. Rather, it is designed to complement the expertise of physicians, reduce diagnostic errors, and enable earlier treatment. Fukuoka explained, “We believe that, by further developing this technology, it could lead to creating a medical infrastructure during comprehensive health check-ups to connect suspected cases of hand-related disorders to specialists. It could support non-specialist physicians in regional healthcare settings, thus contributing to a reduction of healthcare disparities there.”
Acromegaly, as defined by Wikipedia, is a disorder resulting from excess growth hormone, typically occurring after the growth plates have closed. The condition’s impact extends beyond physical changes, potentially leading to complications like high blood pressure and heart problems.
The researchers are continuing to refine their model and explore its potential applications. The next steps involve expanding the dataset to include more diverse populations and conducting larger-scale clinical trials to validate the AI’s performance in real-world settings. The team will also investigate the feasibility of integrating their technology into existing healthcare systems.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Share your thoughts on this innovative use of AI in healthcare in the comments below.
